Publication Annual Report – Annual Shareholders' Meeting
April 15, 2024 11:16 ET
|
Oxurion NV
Publication Annual Report – Annual Shareholders' Meeting Leuven, BELGIUM – April 15, 2024 – 05:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, has...
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
April 11, 2024 13:00 ET
|
Oxurion NV
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC Leuven, BELGIUM – April 11, 2024 – 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program : Eleventh tranche fully issued and paid-up
April 10, 2024 13:00 ET
|
Oxurion NV
Oxurion Receives EUR 450,000 in the framework of the Atlas Funding ProgramEleventh tranche fully issued and paid-up Leuven, BELGIUM, 10 April 2024 – 07.00 PM CET – Oxurion NV (Euronext Brussels:...
Postponement Annual Shareholders Meeting - Amendment financial calendar
April 05, 2024 08:00 ET
|
Oxurion NV
Postponement Annual Shareholders Meeting - Amendment financial calendarLeuven, BELGIUM – April 5, 2024 – 02:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in...
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
March 28, 2024 14:00 ET
|
Oxurion NV
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – March 28, 2024 – 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas - Amended version
March 27, 2024 14:00 ET
|
Oxurion NV
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas - Amended version Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion...
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas
March 26, 2024 14:00 ET
|
Oxurion NV
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR...
OXURION announces its presence at the Paris SmallCap event on March 28, 2024.
March 25, 2024 14:10 ET
|
Oxurion NV
OXURION announces its presence at the Paris SmallCapevent on March 28, 2024. Leuven, BELGIUM - March 25, 2024 - 7:00 p.m, Oxurion NV (Euronext Brussels : OXUR), a Leuven-based biopharmaceutical...
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
March 22, 2024 14:00 ET
|
Oxurion NV
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – March 22, 2024 – 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company...
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas
March 21, 2024 14:00 ET
|
Oxurion NV
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR...